TROPION-Lung12 Phase 3 Trial Begins to Evaluate DATROWAY® as Part of Adjuvant Treatment for High-Risk Early-Stage Non-Small Cell Lung Cancer Patients Non-small cell lung cancer (NSCLC) is the most common…
Enveric Biosciences Announces Notice of Allowance for Patent on Lead Drug Candidate EB-003 Enveric Biosciences, a biotechnology firm focused on pioneering neuroplastogenic small-molecule therapeutics for mental health disorders, announced today…
Science Exchange Launches Clinical Development Solution to Revolutionize Clinical Trial Management Science Exchange, a leader in supplier orchestration solutions for the life sciences industry, has unveiled its new Clinical Development…
Mirvie, a leader in personalized and preventive care for pregnancy complications, recently presented groundbreaking findings at the Society for Maternal-Fetal Medicine annual meeting. The company revealed that its innovative RNA…
Kyowa Kirin and Swixx BioPharma Expand Access to POTELIGEO® for Mycosis Fungoides and Sézary Syndrome in Central and Eastern Europe Kyowa Kirin International (KKI), a fully owned subsidiary of Kyowa…
Osta Therapeutics Expands Leadership Team with Two Industry Experts to Combat Antibiotic Resistance Osta Therapeutics Expands Leadership Team to Tackle Antibiotic Resistance Osta Therapeutics, a biotechnology company focused on developing…
Ethris Announces Promising Phase 1 Clinical Data for mRNA Therapeutic ETH47 in Asthma Treatment Ethris GmbH, a biotechnology pioneer in the development of next-generation RNA therapeutics and vaccines, has announced…
Owkin, a pioneering AI-biotech company dedicated to transforming drug discovery, development, and diagnostics through agentic AI, has announced the dosing of the first patient in its Phase I clinical trial…
Ferrer Earns Compliance Leader Verification™ for Exemplary Ethical and Responsible Corporate Practices Ferrer, a globally recognized pharmaceutical company, has been awarded the prestigious Compliance Leader Verification™ by Ethisphere, an organization…
Virpax Pharmaceuticals Announces Public Offering Pricing to Fuel Drug Development and Innovation Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a forward-thinking preclinical-stage pharmaceutical company specializing in groundbreaking drug delivery systems for pain…
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, has unveiled groundbreaking new data from the Phase III CALGB (Alliance) / SWOG 80702 study. These findings…
Bristol Myers Squibb Presents Results from CheckMate-8HW Analysis Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) Compared to Opdivo Monotherapy in MSI-H/dMMR Metastatic Colorectal Cancer Bristol Myers Squibb (NYSE: BMY) has announced…